Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hemikal
- Development stage
- Unknown
- Lead developer
- Sam-On
- Administration
- Rectal, Topical
01
Overview
Hemikal is a natural-based topical ointment developed and marketed by Meditec for the relief of symptoms associated with hemorrhoids, including pain, itching, burning, and bleeding. Formulated with vaseline, lanolin, propolis extract, and chamomile extract, the ointment acts locally to form a protective barrier over the anal mucosa. This barrier soothes irritation, protects the affected tissue, and facilitates bowel movements without systemic absorption. Hemikal is registered as a medical device in Israel and has European CE mark approval, making it safe for use during pregnancy and lactation.
- Brand names
- Hemikal
- Other names
- המיקל
Beyond the preview
Go deeper on Hemikal.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hemikal.